Phase I clinical and translational evaluation of AZD6738 in combination with durvalumab in patients (pts) with lung or head and neck carcinoma.
暂无分享，去创建一个
Y. Bang | A. El-Khoueiry | S. Im | M. Krebs | S. Postel-Vinay | A. Pierce | A. Berges | S. Hollingsworth | C. Stephens | N. Standifer | L. Khoja | E. Dean | P. Frewer | P. Marco-Casanova | J. López | B. Felicetti | G. Jones | A. Cheung | W. Abidah